Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Harmaline isolated from
Peganum harmala
suppresses growth of esophageal squamous cell carcinoma through targeting
mTOR
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-09-21
DOI
10.1002/ptr.7289
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology : Reproducibility of natural product research
- (2020) Angelo A. Izzo et al. BRITISH JOURNAL OF PHARMACOLOGY
- 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
- (2020) Xueyin Zu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Kidney Pathophysiology, Toxicology, and Drug-Induced Injury in Drug Development
- (2019) Zaher A. Radi INTERNATIONAL JOURNAL OF TOXICOLOGY
- Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells
- (2019) Xueyin Zu et al. PHYTOTHERAPY RESEARCH
- Scutellarin suppresses patient-derived xenograft tumor growth by directly targeting AKT in esophageal squamous cell carcinoma
- (2019) Feifei Liu et al. Cancer Prevention Research
- mTOR: Role in cancer, metastasis and drug resistance
- (2019) Avaniyapuram Kannan Murugan SEMINARS IN CANCER BIOLOGY
- Potentiation of morphine-induced antinociception by harmaline: involvement of μ-opioid and ventral tegmental area NMDA receptors
- (2019) Sakineh Alijanpour et al. PSYCHOPHARMACOLOGY
- Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
- (2018) Manoj Kumar Kashyap et al. Molecular Cancer
- Effects of a Peganum harmala (Zygophyllaceae) preparation for root canal disinfection
- (2018) Mehdi Tabrizizadeh et al. PHYTOTHERAPY RESEARCH
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer
- (2016) Thomas Powles et al. EUROPEAN UROLOGY
- Harmaline-induced amnesia: Possible role of the amygdala dopaminergic system
- (2016) M. Nasehi et al. NEUROSCIENCE
- mTORC1 and mTORC2 in cancer and the tumor microenvironment
- (2016) L C Kim et al. ONCOGENE
- Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma
- (2015) Shau-Hsuan Li et al. SURGERY
- Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma
- (2015) Jianjun Lu et al. Biomed Research International
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Esophageal Carcinoma
- (2014) Anil K. Rustgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study
- (2013) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma
- (2012) A Naing et al. BRITISH JOURNAL OF CANCER
- Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma
- (2012) K Hirashima et al. BRITISH JOURNAL OF CANCER
- Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma
- (2012) Seok-Hyung Kim et al. HUMAN PATHOLOGY
- Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer
- (2010) Sara M. Johnson et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- A comprehensive map of the mTOR signaling network
- (2010) Etienne Caron et al. Molecular Systems Biology
- Class I PI3K in oncogenic cellular transformation
- (2008) L Zhao et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started